What Is the Embryo Transfer Success Rate in 2026?
New research presented in 2026 offers encouraging evidence about modern IVF outcomes. A large Australian study of 18,396 women reported an estimated 68.2% cumulative live birth rate over three IVF cycles, while using single-embryo transfer in 95.3% of transfers. The multiple-birth rate was only 2.9%. The study suggests that modern laboratory practices and single-embryo transfer can support strong cumulative outcomes without the added risks associated with routinely transferring multiple embryos.
That does not mean every embryo transfer has a 68.2% chance of success. The figure is a cumulative estimate across as many as three cycles, not a per-transfer rate. Individual outcomes still depend on what “success” means, the age of the person whose eggs created the embryo, embryo development and testing, the fertility clinic, and the recipient’s medical circumstances.
For intended parents considering IVF, egg donation, or gestational surrogacy, the most important first step is to ask exactly what a quoted “success rate” measures. A positive pregnancy test, clinical pregnancy, live birth per transfer, and cumulative live birth rate are different outcomes and they should never be compared as though they mean the same thing.
This guide combines the latest 2026 research with the newest available U.S. national data, explains the factors that can influence embryo transfer outcomes, and outlines the questions to ask before beginning a transfer cycle.
Quick answer: A good embryo transfer success rate cannot be reduced to one universal percentage. New 2026 research reported a 68.2% estimated cumulative live birth rate across three IVF cycles—not per transfer—with single-embryo transfer used in 95.3% of transfers. Age at egg retrieval, embryo characteristics, clinic and laboratory practices, uterine health, and the way results are calculated all matter.
What Is the Newest Embryo Transfer Research in 2026?
A study published in the July 2026 supplement of Human Reproduction and presented through the European Society of Human Reproduction and Embryology examined contemporary IVF outcomes across seven Australian fertility clinics. It included 18,396 women beginning their first IVF cycle and followed treatment for up to three retrieval cycles and their associated embryo transfers.
The researchers reported:
58.7% cumulative live birth rate in the intention-to-treat analysis, which counted all participants who started treatment without adjusting for those who discontinued
68.2% estimated cumulative live birth rate in the optimal analysis, which accounted for treatment discontinuation using time-to-event methods
95.3% single-embryo transfer rate
2.9% multiple-birth rate
An estimated three-cycle cumulative live birth rate of 84.5% for patients under 35, 74.4% for ages 35–37, 57.7% for ages 38–40, and 30.1% for ages 41–42
These results are especially relevant because they measure the cumulative chance of live birth over repeated modern IVF treatment—not merely the result of one transfer. The study included contemporary practices such as blastocyst culture, embryo vitrification, frozen embryo transfer when indicated, and near-universal single-embryo transfer.
There are important limitations. This was a retrospective study from one Australian clinic network, the data covered patients who began treatment between 2012 and 2021, and gestational carrier cycles were excluded. The “optimal” 68.2% figure is an estimate that accounts for patients who stopped treatment; the more conservative intention-to-treat result was 58.7%. The findings therefore should not be presented as a guaranteed success rate or as a direct measure of U.S. surrogacy outcomes.
Still, the central finding is meaningful: strong cumulative live birth outcomes can be achieved while transferring one embryo at a time. Read the 2026 study abstract in Human Reproduction.
What Did a Major 2025 Study Find About Repeated Transfers?
A peer-reviewed 2025 study in Human Reproduction analyzed 31,478 transfers of untested embryos among 11,463 women. Researchers found that cumulative live birth rates continued to rise with additional blastocyst transfers, reaching an estimated 68.3% after six blastocyst transfers and 78.0% after ten.
Age still made a substantial difference. After four blastocyst transfers, the estimated cumulative live birth rate was 68.9% for patients younger than 35, compared with 42.9% for ages 38–40 and 16.3% for ages 41–42. The research also found that blastocyst-stage transfer and a higher proportion of good- or excellent-quality embryos were associated with better outcomes.
This does not mean patients should automatically continue through a fixed number of transfers. The study was retrospective, excluded donor-egg and gestational-carrier cycles, and included treatment dating back to 2010. Its practical message is that an unsuccessful transfer does not necessarily mean future transfers cannot succeed. Patients should review embryo factors, age, medical history, and treatment strategy with their reproductive specialist before deciding what comes next. Read the 2025 peer-reviewed study in Human Reproduction.
How Is Embryo Transfer Success Measured?
Clinics may use several different measures when discussing IVF success:
Measure | What it means | Why it matters |
Positive pregnancy test rate | A blood test detects the pregnancy hormone hCG after transfer | This is an early result and does not confirm an ongoing pregnancy |
Clinical pregnancy rate | An ultrasound confirms a clinical pregnancy, usually including a gestational sac | More meaningful than a positive test, but not every clinical pregnancy leads to birth |
Implantation rate | The number of gestational sacs relative to the number of embryos transferred | Useful for assessing implantation, but it is not a live birth rate |
Live birth rate per transfer | The percentage of embryo transfers resulting in at least one live-born baby | Often the most useful measure when evaluating a specific transfer |
Cumulative live birth rate | The chance of a live birth across all eligible transfers associated with one egg retrieval | Offers a broader view of the potential of one retrieval cycle |
Always check the denominator, too. A rate measured per transfer excludes cycles that never reached transfer, while a rate measured per intended retrieval or cycle start includes more of the treatment journey and is usually lower.
What Do the Latest U.S. National IVF Success Rates Show?
U.S. national reporting is necessarily delayed because pregnancies must be followed through birth and clinic data must be collected and reviewed. As of September 2026, the preliminary 2024 SART National Summary Report is the newest SART national summary available. It includes data from SART member clinics and reports 431,746 total cycles. For patients using their own eggs, SART reported the following live birth rates for the first embryo transfer:
Age of patient whose eggs were used | Live birth per first transfer | Live birth per intended egg retrieval, including all transfers reported in the summary |
Under 35 | 53.6% | 41.7% |
35–37 | 50.6% | 29.6% |
38–40 | 45.6% | 18.5% |
41–42 | 35.2% | 8.8% |
Older than 42 | 16.5% | 2.8% |
These figures answer different questions. The per-transfer figure describes outcomes among patients who reached a first transfer. The intended-retrieval figure includes the wider group who began treatment, including those who did not ultimately have an embryo suitable for transfer.
SART identifies its 2024 report as preliminary. The Centers for Disease Control and Prevention also publishes clinic-level and national assisted reproductive technology data, but its public reporting likewise trails current treatment. This is why a responsible 2026 overview should use two types of evidence together: the newest national registry data for broad U.S. benchmarks and newer 2025–2026 studies for current clinical insights.
Which Factors Affect Embryo Transfer Success Rates Most?
1. Age of the egg source
When intended parents use their own eggs, age at egg retrieval is one of the strongest predictors of IVF outcome. The chance that an embryo has the expected number of chromosomes generally decreases as the egg source ages. This helps explain why national live birth rates decline across older age groups.
In a donor-egg journey, the donor’s age—not the intended mother’s age—is generally more relevant to embryo-related age risk. The health and preparation of the person carrying the pregnancy still matter, but a gestational carrier does not contribute eggs to the embryo.
2. Embryo development and quality
Clinics assess embryos by their developmental stage, appearance, and, in some cases, genetic testing results. Many embryos are transferred at the blastocyst stage, usually on day five, six, or sometimes seven after fertilization. Reaching the blastocyst stage provides the laboratory with more information about development, although grading alone cannot guarantee implantation or a live birth.
3. Chromosomal status and PGT-A
Preimplantation genetic testing for aneuploidy, or PGT-A, screens biopsied embryo cells for chromosome-number differences. Transferring an embryo reported as euploid can improve embryo selection and may raise the live birth rate per transfer in some groups. However, PGT-A does not guarantee pregnancy, and it does not improve cumulative live birth outcomes for every patient.
The American Society for Reproductive Medicine’s 2024 committee opinion on PGT-A states that routine PGT-A for every IVF patient cannot currently be recommended. It may be helpful in selected circumstances, including some patients of advanced maternal age, but the decision should be individualized with a reproductive endocrinologist and, when appropriate, a genetic counselor.
4. Uterine health and endometrial preparation
Polyps, some fibroids, uterine scarring, inflammation, and other medical factors may affect implantation. Before a gestational carrier is medically cleared, the fertility clinic typically reviews her pregnancy history, overall health, and uterine evaluation.
Frozen embryo transfer preparation may use a programmed cycle with estrogen and progesterone or a natural or modified-natural cycle timed around ovulation. No single protocol is best for every patient or gestational carrier. The treating physician should select the protocol based on medical history, cycle regularity, and current clinical evidence.
5. Fertility laboratory and clinic experience
Embryo culture, biopsy, freezing, thawing, and transfer all require carefully controlled laboratory and clinical processes. Intended parents should review clinic-specific outcomes for patients with circumstances similar to theirs rather than relying only on an overall headline rate.
6. Number of embryos transferred
Transferring more than one embryo may increase the chance of multiple pregnancy without producing a proportional improvement in the chance of a healthy singleton birth. Multiple pregnancy raises risks for both the pregnant person and babies. ASRM generally recommends single-embryo transfer in favorable circumstances and recommends transferring one euploid embryo regardless of age.
Is a Frozen Embryo Transfer More Successful Than a Fresh Transfer?
Not always. Frozen embryo transfer, or FET, is now widely used because it allows time for genetic testing when selected, separates ovarian stimulation from transfer, and gives the medical team flexibility in preparing the uterine lining. A freeze-all approach may also be recommended when there is a risk of ovarian hyperstimulation syndrome or when the uterine environment is not considered optimal for a fresh transfer.
However, it is too broad to say that frozen transfers are universally more successful. Outcomes depend on the patient group, embryo source, reason for freezing, clinic protocols, and whether results are calculated per transfer or per retrieval. Some studies and patient groups show an advantage with frozen transfer; others show similar outcomes or no cumulative live birth benefit.
The best question is not simply “fresh or frozen?” It is: Which transfer strategy is medically appropriate for this embryo, this recipient, and this treatment plan?
Does Using a Gestational Surrogate Increase Embryo Transfer Success?
A gestational surrogate may provide an appropriate path when carrying a pregnancy is medically impossible, unsafe, or unsuccessful for an intended parent. Surrogates complete medical and psychosocial screening before approval, and they usually have a history of at least one uncomplicated pregnancy and birth.
Even with a carefully screened surrogate, no agency or clinic can guarantee that a particular embryo will implant or lead to a live birth. Embryo factors—especially the age of the egg source and embryo competence—remain highly important. Uterine health, treatment protocol, and laboratory performance also contribute to the outcome.
ACRC Global reports a 96% Surro-baby Live Birth Rate across its program. This agency-level figure describes outcomes across managed surrogacy journeys and should not be interpreted as the probability that one embryo transfer will succeed. Clinic transfer rates and agency journey-level rates use different denominators and measure different parts of the process.
Why Clinic Success Rates Cannot Be Compared at Face Value
One clinic’s 65% rate and another clinic’s 50% rate may not represent an equal comparison. Before drawing conclusions, ask:
Is the result a pregnancy rate or a live birth rate?
Is it measured per cycle start, retrieval, or transfer?
Does it include only patients who had an embryo available for transfer?
Are the embryos tested or untested?
Are the eggs from intended parents or donors?
Which age group does the number represent?
Does the clinic treat medically complex patients who may have lower expected outcomes?
How many cycles are included, and is the sample large enough to be meaningful?
The CDC cautions that national and clinic averages may not reflect an individual patient’s chance of success. Use published data to begin a conversation with a fertility specialist, not as a promise or prediction.
Questions to Ask Before an Embryo Transfer
Bring these questions to your reproductive endocrinologist or fertility clinic:
What is my estimated live birth rate per transfer and per retrieval?
Which age, diagnosis, and embryo group is that estimate based on?
Are you quoting outcomes for tested embryos, untested embryos, or both?
How many embryos do you recommend transferring, and why?
Would PGT-A be useful in my circumstances, and what are its limitations?
Do you recommend a fresh, natural-cycle frozen, or programmed frozen transfer for this case?
What evaluation will the gestational carrier complete before medical clearance?
How does your clinic coordinate medication, monitoring, and transfer timing for an out-of-state surrogate?
What happens if the first transfer is unsuccessful?
Which expenses and timelines could change if another transfer is needed?
Embryo Transfer Success Rate FAQs
What is a good embryo transfer success rate?
There is no single rate that is “good” for everyone. The 2026 Australian study reported a 58.7% observed cumulative live birth rate and a 68.2% estimated cumulative rate across up to three cycles, but those are not per-transfer figures. In SART’s preliminary 2024 U.S. report, live birth per first transfer using a patient’s own eggs ranged from 53.6% for patients under 35 to 16.5% for patients over 42. Your relevant benchmark depends on egg-source age, embryo type, medical history, testing, and the clinic’s patient population.
What is the difference between implantation and live birth rates?
Implantation means that an embryo attached and produced evidence of early pregnancy. A live birth rate measures whether treatment resulted in a baby born alive. Because some pregnancies end before birth, the live birth rate is the more meaningful endpoint for most intended parents.
Does a euploid embryo guarantee a successful transfer?
No. A euploid PGT-A result indicates that the sampled cells had the expected chromosome number, but it does not evaluate every factor involved in implantation or fetal development. Test limitations, embryo biology, uterine factors, and other medical variables still matter.
Does the intended mother’s age matter when donor eggs are used?
The donor’s age is generally more relevant to embryo-related age risk because her eggs create the embryos. The intended mother’s or gestational carrier’s health still matters if she will carry the pregnancy.
Does the gestational surrogate’s age affect success?
A surrogate’s overall health, obstetric history, uterine health, and medical clearance are more informative than age alone. Reputable programs and fertility clinics apply age and health criteria as part of a broader screening process.
How many embryo transfers are usually needed for a live birth?
There is no universal number. Some journeys succeed after the first transfer, while others require additional attempts. Ask the clinic for both its live birth rate per transfer and its cumulative live birth rate for patients and embryos similar to yours.
How long after embryo transfer can pregnancy be confirmed?
Clinics commonly schedule a blood hCG test approximately nine to fourteen days after transfer, although timing varies. A later ultrasound is needed to confirm a clinical pregnancy. Follow the testing schedule provided by the treating clinic.
Can an embryo transfer success rate predict my personal outcome?
No. Published rates describe groups, not individuals. A reproductive endocrinologist can provide a more personalized estimate after reviewing egg-source age, embryo history, genetic testing if applicable, prior treatment, and the recipient’s medical evaluation.
Planning an Embryo Transfer in a Surrogacy Journey
Embryo transfer is one important milestone within a much larger surrogacy process. Intended parents also need coordinated surrogate screening, matching, independent legal representation, insurance review, escrow arrangements, medical scheduling, pregnancy support, and parentage planning.
ACRC Global supports intended parents across the United States and internationally with surrogate matching, fertility coordination, donor options, and case management from consultation through birth. Our team can help you understand how embryo readiness, surrogate screening, clinic requirements, legal clearance, and transfer planning fit together.
Book a Free Consultation With ACRC Global
If you are considering gestational surrogacy, egg donation, or IVF support, you do not need to interpret the process alone. Speak with the ACRC Global team about your goals, where you are in treatment, and the next steps that may apply to your journey.
Book your free consultation with ACRC Global and begin building a personalized path toward parenthood.
Medical Disclaimer
This article is for general educational purposes only and does not constitute medical, genetic, legal, or financial advice. IVF and embryo transfer outcomes vary by individual circumstances. Consult a qualified reproductive endocrinologist and other appropriate professionals before making treatment decisions. Success rates are historical group-level data and do not guarantee an individual outcome.
Sources
About the author:
Comments